Advances in Particle Therapy
A Multidisciplinary Approach
Herausgeber: Dosanjh, Manjit; Bernier, Jacques
Advances in Particle Therapy
A Multidisciplinary Approach
Herausgeber: Dosanjh, Manjit; Bernier, Jacques
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This text covers the most recent advances in hadron therapy, exploring the physics, technology, biology, diagnosis, clinical applications, and economics behind the therapy. It will be of interest to current and aspiring specialists from a wide range of backgrounds.
Andere Kunden interessierten sich auch für
- Monte Carlo Techniques in Radiation Therapy267,99 €
- Beam's Eye View Imaging in Radiation Oncology263,99 €
- Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy287,99 €
- Quantitative MRI in Cancer220,99 €
- Big Data in Radiation Oncology224,99 €
- Jim MaloneEthics for Radiation Protection in Medicine123,99 €
- Loredana G MarcuRadiotherapy and Clinical Radiobiology of Head and Neck Cancer154,99 €
-
-
-
This text covers the most recent advances in hadron therapy, exploring the physics, technology, biology, diagnosis, clinical applications, and economics behind the therapy. It will be of interest to current and aspiring specialists from a wide range of backgrounds.
Produktdetails
- Produktdetails
- Verlag: Bsp Books Pvt. Ltd.
- Seitenzahl: 282
- Erscheinungstermin: 27. Mai 2022
- Englisch
- Abmessung: 261mm x 184mm x 22mm
- Gewicht: 798g
- ISBN-13: 9781138064416
- ISBN-10: 1138064416
- Artikelnr.: 52963233
- Verlag: Bsp Books Pvt. Ltd.
- Seitenzahl: 282
- Erscheinungstermin: 27. Mai 2022
- Englisch
- Abmessung: 261mm x 184mm x 22mm
- Gewicht: 798g
- ISBN-13: 9781138064416
- ISBN-10: 1138064416
- Artikelnr.: 52963233
Manjit Dosanjh is the co-ordinator of the Technology Transfer Network and Biomedical Applications in the Education and Technology Transfer Division at CERN and a Health Consultant for the Forum for Health. She is also the co-ordinator of ENLIGHT (the European Network for Light Ion Hadron Therapy). Jacques Bernier is the Medical Director of the Oncology Department of the Clinique de Genolier and the Integrated Center for Radiation Oncology of Eaux-Vives in Geneva. He is also Course Director at the European School of Oncology.
From Röntgen Rays to Carbon Ion Therapy: The Evolution of Modern Radiation
Oncology. Radiobiology and Hadron Therapy: What Do We Know and What Do We
Need to Know? Challenges Surrounding RBE for Particle Therapy: Where Do We
Go from Here? Advances in Beam Delivery Techniques and Accelerators in
Particle Therapy. Requirements for setting up a Particle Therapy Center.
Imaging and Particle Therapy: Current Status and Future Perspectives. Why
particle therapy rather than photon therapy or how to integrate the
decision into multimodal management. Role of Multidisciplinary
Collaborative Network for Advancing Cancer Therapy. Long-term outcomes and
prognostic factors in patients with indications for particle therapy in
sarcomas. Proton therapy for pediatric patients. NTCP Reduction in Advanced
Head and Neck Cancer Patients Using Proton Therapy. The model-based
approach to select patients for proton therapy and to validate its added
value. Overview of Carbon-Ion Radiotherapy in Japan. Particle therapy
clinical trials: perspectives from Europe, Japan and USA. Role of Particle
Therapy in Future Radiotherapy practice. Health Economics: Cost,
Cost-Effectiveness and Budget Impact of Particle Therapy. Big data-based
Decision Support systems for Hadrontherapy. Cern Collaborations in Hadron
Therapy and Future Accelerators. Addressing Global Challenges for Radiation
Therapy: From "C" to shining "C" (Cobalt to Carbon) and the "Radiation
Rotary".
Oncology. Radiobiology and Hadron Therapy: What Do We Know and What Do We
Need to Know? Challenges Surrounding RBE for Particle Therapy: Where Do We
Go from Here? Advances in Beam Delivery Techniques and Accelerators in
Particle Therapy. Requirements for setting up a Particle Therapy Center.
Imaging and Particle Therapy: Current Status and Future Perspectives. Why
particle therapy rather than photon therapy or how to integrate the
decision into multimodal management. Role of Multidisciplinary
Collaborative Network for Advancing Cancer Therapy. Long-term outcomes and
prognostic factors in patients with indications for particle therapy in
sarcomas. Proton therapy for pediatric patients. NTCP Reduction in Advanced
Head and Neck Cancer Patients Using Proton Therapy. The model-based
approach to select patients for proton therapy and to validate its added
value. Overview of Carbon-Ion Radiotherapy in Japan. Particle therapy
clinical trials: perspectives from Europe, Japan and USA. Role of Particle
Therapy in Future Radiotherapy practice. Health Economics: Cost,
Cost-Effectiveness and Budget Impact of Particle Therapy. Big data-based
Decision Support systems for Hadrontherapy. Cern Collaborations in Hadron
Therapy and Future Accelerators. Addressing Global Challenges for Radiation
Therapy: From "C" to shining "C" (Cobalt to Carbon) and the "Radiation
Rotary".
From Röntgen Rays to Carbon Ion Therapy: The Evolution of Modern Radiation
Oncology. Radiobiology and Hadron Therapy: What Do We Know and What Do We
Need to Know? Challenges Surrounding RBE for Particle Therapy: Where Do We
Go from Here? Advances in Beam Delivery Techniques and Accelerators in
Particle Therapy. Requirements for setting up a Particle Therapy Center.
Imaging and Particle Therapy: Current Status and Future Perspectives. Why
particle therapy rather than photon therapy or how to integrate the
decision into multimodal management. Role of Multidisciplinary
Collaborative Network for Advancing Cancer Therapy. Long-term outcomes and
prognostic factors in patients with indications for particle therapy in
sarcomas. Proton therapy for pediatric patients. NTCP Reduction in Advanced
Head and Neck Cancer Patients Using Proton Therapy. The model-based
approach to select patients for proton therapy and to validate its added
value. Overview of Carbon-Ion Radiotherapy in Japan. Particle therapy
clinical trials: perspectives from Europe, Japan and USA. Role of Particle
Therapy in Future Radiotherapy practice. Health Economics: Cost,
Cost-Effectiveness and Budget Impact of Particle Therapy. Big data-based
Decision Support systems for Hadrontherapy. Cern Collaborations in Hadron
Therapy and Future Accelerators. Addressing Global Challenges for Radiation
Therapy: From "C" to shining "C" (Cobalt to Carbon) and the "Radiation
Rotary".
Oncology. Radiobiology and Hadron Therapy: What Do We Know and What Do We
Need to Know? Challenges Surrounding RBE for Particle Therapy: Where Do We
Go from Here? Advances in Beam Delivery Techniques and Accelerators in
Particle Therapy. Requirements for setting up a Particle Therapy Center.
Imaging and Particle Therapy: Current Status and Future Perspectives. Why
particle therapy rather than photon therapy or how to integrate the
decision into multimodal management. Role of Multidisciplinary
Collaborative Network for Advancing Cancer Therapy. Long-term outcomes and
prognostic factors in patients with indications for particle therapy in
sarcomas. Proton therapy for pediatric patients. NTCP Reduction in Advanced
Head and Neck Cancer Patients Using Proton Therapy. The model-based
approach to select patients for proton therapy and to validate its added
value. Overview of Carbon-Ion Radiotherapy in Japan. Particle therapy
clinical trials: perspectives from Europe, Japan and USA. Role of Particle
Therapy in Future Radiotherapy practice. Health Economics: Cost,
Cost-Effectiveness and Budget Impact of Particle Therapy. Big data-based
Decision Support systems for Hadrontherapy. Cern Collaborations in Hadron
Therapy and Future Accelerators. Addressing Global Challenges for Radiation
Therapy: From "C" to shining "C" (Cobalt to Carbon) and the "Radiation
Rotary".